Technical Analysis for NOTV - Inotiv, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 3.32 | 3.43% | 0.11 |
NOTV closed up 15.05 percent on Wednesday, November 20, 2024, on 8.63 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: Dec 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 3.43% | |
| Shooting Star Candlestick | Bearish | 3.43% | |
| Lizard Bearish | Bearish Day Trade Setup | 3.43% | |
| Pocket Pivot | Bullish Swing Setup | 3.43% | |
| Volume Surge | Other | 3.43% | |
| Calm After Storm | Range Contraction | 3.43% | |
| Wide Range Bar | Range Expansion | 3.43% | |
| Doji - Bearish? | Reversal | 3.43% | |
| Parabolic Rise | Strength | 3.43% | |
| Wide Bands | Range Expansion | 3.43% |
| Alert | Time |
|---|---|
| 200 DMA Resistance | about 2 hours ago |
| 2x Volume Pace | about 2 hours ago |
| 1.5x Volume Pace | about 2 hours ago |
| 3x Volume Pace | about 2 hours ago |
| Up 5% | about 2 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 12/09/2024
Inotiv, Inc. is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Health Sciences Pharmacy Health Care Pharmacology Drug Development Pharmaceutical Sciences Contract Research Organizations Contract Research Services
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Health Sciences Pharmacy Health Care Pharmacology Drug Development Pharmaceutical Sciences Contract Research Organizations Contract Research Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.4166 |
| 52 Week Low | 1.227 |
| Average Volume | 265,714 |
| 200-Day Moving Average | 3.45 |
| 50-Day Moving Average | 1.98 |
| 20-Day Moving Average | 2.37 |
| 10-Day Moving Average | 2.90 |
| Average True Range | 0.34 |
| RSI (14) | 71.91 |
| ADX | 34.56 |
| +DI | 42.15 |
| -DI | 10.77 |
| Chandelier Exit (Long, 3 ATRs) | 2.77 |
| Chandelier Exit (Short, 3 ATRs) | 2.65 |
| Upper Bollinger Bands | 3.51 |
| Lower Bollinger Band | 1.24 |
| Percent B (%b) | 0.87 |
| BandWidth | 95.44 |
| MACD Line | 0.32 |
| MACD Signal Line | 0.27 |
| MACD Histogram | 0.0475 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.23 | ||||
| Resistance 3 (R3) | 4.31 | 4.04 | 4.06 | ||
| Resistance 2 (R2) | 4.04 | 3.78 | 4.00 | 4.00 | |
| Resistance 1 (R1) | 3.63 | 3.62 | 3.83 | 3.55 | 3.95 |
| Pivot Point | 3.36 | 3.36 | 3.47 | 3.32 | 3.36 |
| Support 1 (S1) | 2.95 | 3.10 | 3.16 | 2.87 | 2.47 |
| Support 2 (S2) | 2.68 | 2.94 | 2.65 | 2.42 | |
| Support 3 (S3) | 2.27 | 2.68 | 2.36 | ||
| Support 4 (S4) | 2.19 |
